Welcome to our simulation interface
Lopinavir & Ritonavir
This simulation is for informative purposes only.
For simulations, please enter Lopinavir dose only.
The Lopinavir/Ritonavir ratio assumed is 4:1
The population (196 persons for 1662 blood samples) was pooled from 6 studies. Patients were HIV-1-positives. The aim of the study was to observe the effects of age from infants to adults (age range covered: 0.0115 to 63 years), weight (3.6 to 97.5 kg) and formulation (gel-capsule, liquid, melt-extrusion tablets) on PK.